Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free BSFA Stock Alerts

BSF Enterprise (BSFA) Competitors

BSF Enterprise logo
GBX 2.60 -0.52 (-16.74%)
As of 12:51 PM Eastern
Compare

BSFA vs. HALO, IDP, OPTI, IRON, and BON

Should you buy BSF Enterprise stock or one of its competitors? MarketBeat compares BSF Enterprise with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BSF Enterprise include HaloSource (HALO), InnovaDerma (IDP), OptiBiotix Health (OPTI), Ironveld (IRON), and Bonmarche (BON). These companies are all part of the "pharmaceutical products" industry.

How does BSF Enterprise compare to HaloSource?

HaloSource (LON:HALO) and BSF Enterprise (LON:BSFA) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

In the previous week, BSF Enterprise had 4 more articles in the media than HaloSource. MarketBeat recorded 4 mentions for BSF Enterprise and 0 mentions for HaloSource. BSF Enterprise's average media sentiment score of 0.62 beat HaloSource's score of 0.00 indicating that BSF Enterprise is being referred to more favorably in the news media.

Company Overall Sentiment
HaloSource Neutral
BSF Enterprise Positive

HaloSource has a net margin of 0.00% compared to BSF Enterprise's net margin of -2,107.40%. HaloSource's return on equity of 0.00% beat BSF Enterprise's return on equity.

Company Net Margins Return on Equity Return on Assets
HaloSourceN/A N/A N/A
BSF Enterprise -2,107.40%-39.69%-20.65%

HaloSource has higher earnings, but lower revenue than BSF Enterprise. BSF Enterprise is trading at a lower price-to-earnings ratio than HaloSource, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HaloSourceN/AN/AN/A-£5.17N/A
BSF Enterprise£52.84K82.17-£2.04M-£0.91N/A

Summary

HaloSource and BSF Enterprise tied by winning 4 of the 8 factors compared between the two stocks.

How does BSF Enterprise compare to InnovaDerma?

BSF Enterprise (LON:BSFA) and InnovaDerma (LON:IDP) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

In the previous week, BSF Enterprise had 4 more articles in the media than InnovaDerma. MarketBeat recorded 4 mentions for BSF Enterprise and 0 mentions for InnovaDerma. BSF Enterprise's average media sentiment score of 0.62 beat InnovaDerma's score of 0.00 indicating that BSF Enterprise is being referred to more favorably in the media.

Company Overall Sentiment
BSF Enterprise Positive
InnovaDerma Neutral

InnovaDerma has a net margin of 0.00% compared to BSF Enterprise's net margin of -2,107.40%. InnovaDerma's return on equity of 0.00% beat BSF Enterprise's return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,107.40% -39.69% -20.65%
InnovaDerma N/A N/A N/A

InnovaDerma has higher revenue and earnings than BSF Enterprise. BSF Enterprise is trading at a lower price-to-earnings ratio than InnovaDerma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£52.84K82.17-£2.04M-£0.91N/A
InnovaDerma£9.82M0.00N/A-£7.50N/A

Summary

BSF Enterprise and InnovaDerma tied by winning 4 of the 8 factors compared between the two stocks.

How does BSF Enterprise compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and BSF Enterprise (LON:BSFA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

OptiBiotix Health has a net margin of -333.62% compared to BSF Enterprise's net margin of -2,107.40%. BSF Enterprise's return on equity of -39.69% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
BSF Enterprise -2,107.40%-39.69%-20.65%

0.4% of OptiBiotix Health shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by insiders. Comparatively, 18.0% of BSF Enterprise shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

OptiBiotix Health has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market. Comparatively, BSF Enterprise has a beta of 3.593, indicating that its share price is 259% more volatile than the broader market.

BSF Enterprise has lower revenue, but higher earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than BSF Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M5.41-£3.09M-£0.03N/A
BSF Enterprise£52.84K82.17-£2.04M-£0.91N/A

In the previous week, OptiBiotix Health and OptiBiotix Health both had 4 articles in the media. OptiBiotix Health's average media sentiment score of 0.93 beat BSF Enterprise's score of 0.62 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OptiBiotix Health
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BSF Enterprise
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

OptiBiotix Health beats BSF Enterprise on 7 of the 12 factors compared between the two stocks.

How does BSF Enterprise compare to Ironveld?

BSF Enterprise (LON:BSFA) and Ironveld (LON:IRON) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

BSF Enterprise has a beta of 3.593, suggesting that its share price is 259% more volatile than the broader market. Comparatively, Ironveld has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market.

Ironveld has lower revenue, but higher earnings than BSF Enterprise. Ironveld is trading at a lower price-to-earnings ratio than BSF Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£52.84K82.17-£2.04M-£0.91N/A
Ironveld£4K1,139.59N/A-£0.00N/A

6.2% of Ironveld shares are held by institutional investors. 18.0% of BSF Enterprise shares are held by insiders. Comparatively, 25.3% of Ironveld shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, BSF Enterprise had 4 more articles in the media than Ironveld. MarketBeat recorded 4 mentions for BSF Enterprise and 0 mentions for Ironveld. BSF Enterprise's average media sentiment score of 0.62 beat Ironveld's score of 0.00 indicating that BSF Enterprise is being referred to more favorably in the media.

Company Overall Sentiment
BSF Enterprise Positive
Ironveld Neutral

Ironveld has a net margin of -526.22% compared to BSF Enterprise's net margin of -2,107.40%. Ironveld's return on equity of -7.17% beat BSF Enterprise's return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,107.40% -39.69% -20.65%
Ironveld -526.22%-7.17%-1.97%

Summary

Ironveld beats BSF Enterprise on 7 of the 12 factors compared between the two stocks.

How does BSF Enterprise compare to Bonmarche?

BSF Enterprise (LON:BSFA) and Bonmarche (LON:BON) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

In the previous week, BSF Enterprise had 3 more articles in the media than Bonmarche. MarketBeat recorded 4 mentions for BSF Enterprise and 1 mentions for Bonmarche. BSF Enterprise's average media sentiment score of 0.62 beat Bonmarche's score of 0.00 indicating that BSF Enterprise is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BSF Enterprise
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bonmarche
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bonmarche has a net margin of 0.00% compared to BSF Enterprise's net margin of -2,107.40%. Bonmarche's return on equity of 0.00% beat BSF Enterprise's return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,107.40% -39.69% -20.65%
Bonmarche N/A N/A N/A

Bonmarche has higher revenue and earnings than BSF Enterprise. BSF Enterprise is trading at a lower price-to-earnings ratio than Bonmarche, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£52.84K82.17-£2.04M-£0.91N/A
Bonmarche£186.15M0.00N/A£9.30N/A

Summary

Bonmarche beats BSF Enterprise on 6 of the 8 factors compared between the two stocks.

Get BSF Enterprise News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSFA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSFA vs. The Competition

Export
MetricBSF EnterpriseBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.34M£464.32M£6.47B£2.78B
Dividend YieldN/A3.87%2.69%6.13%
P/E Ratio-2.863.1118.89364.74
Price / Sales82.176,509.16520.7987,565.33
Price / Cash10.3013.1341.3427.85
Price / Book0.8484.759.847.71
Net Income-£2.04M-£96.07M£3.57B£5.89B
7 Day Performance48.69%-0.06%-1.16%0.07%
1 Month Performance38.55%0.75%3.85%3.26%
1 Year Performance-1.06%74.31%27.40%75.52%

BSF Enterprise Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSFA
BSF Enterprise
N/AGBX 2.60
-16.7%		N/A+40.4%£4.34M£52.84KN/A12
HALO
HaloSource
N/AGBX 8.68
-4.9%		N/AN/A£10.11MN/AN/A390
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82MN/A8,720
OPTI
OptiBiotix Health
N/AGBX 5.50
-4.3%		N/A-51.2%£5.94M£1.15MN/A1
IRON
Ironveld
N/AGBX 0.02
flat		N/A-48.9%£4.56M£4KN/A30

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BSFA) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel